cerrar
Tagged with Biotech,

Interview: Kennet Brysting – General Manager, Gilead…
Kennet Brysting, General Manager of Gilead Sciences Canada, Inc. outlines the strategic significance of the Canadian affiliate to Gilead Sciences…

Austria: Orchestrating Innovation
Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research giants, Germany and Switzerland. Now,…

Interview: Arnoldas Doviltis – General Manager, Ferring…
Arnoldas Doviltis, general manager of Ferring Austria, a research-driven Swiss biopharmaceutical company, elaborates on the autonomous nature of local…

Interview: Erich Lehner – Head of Life Science Branch, EY…
Erich Lehner, head of the life science branch at EY Austria, a worldwide leading consultancy firm, provides an insight into the current mandate of EY…

Interview: Michael Krebs – Managing Director, Institute of…
Michael Krebs, managing director of the Institute of Molecular Biotechnology (IMBA), the leading publicly funded non-university biomedical research…

Interview: Philipp von Lattorff – Country Managing…
Philipp von Lattorff, country managing director of Boehringer Ingelheim’s Regional Centre Vienna (RCV) discusses the current mandate of the center…

Interview: Oscar Fernando Otalora Gomez – Executive…
Oscar Fernando Otalora Gomez, Executive Director of HB Human Bioscience, discusses the importance of bringing innovation and technology to the…

Interview: Sylvia Hofinger – Director General, Association…
Sylvia Hofinger, director general of the Association of the chemical industry of Austria (FCIO), the representing voice of the Austrian chemical…

Interview: Evie Yulin – Country Director, Merck Biopharma…
Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging countries and how the company engages…

Interview: Sandra Cifuentes – General Manager, Astellas…
Sandra Cifuentes, General Manager of Astellas Farma Colombia, one of the most recent entrants in the Colombian market, explains the strategic…

Hong Kong: Land of the Biotech Unicorns
In 2017, Hong Kong fended off perennial competitors, life sciences hubs and innovation powerhouses, Switzerland and Singapore, to rank first in the…

Interview: Dennis Lo – Co-Founder, Cirina; Professor of…
Described as the first unicorn [a startup company valued at over USD 1 billion] of Hong Kong, Cirina has recently merged with Grail to further improve…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here